US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers: market research reports

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers can be valuable tools in clinical diagnostics as well as in therapeutic discovery and development.
They can be used to predict response to therapy or risk of side effects for personalized medicine applications. Additional types include predisposition, screening, diagnostic, prognostic, toxicity, pharmacodynamic, and other biomarkers.

The existence of living organisms or biological processes, a particular disease state, or a fragment of DNA sequence can indicate biomarkers. Locations of a particular molecule (cellular or subcellular, tissue or organ locations) can also be a biomarker.

Biomarkers ideal for diagnosis should have great sensitivity, specificity, and accuracy in reflecting total disease burden. A tumor marker should also be prognostic of outcome and predictive of tumor recurrence and effectiveness of anti-cancer treatments.

Biomarkers for screening purposes must be highly specific, minimizing false positive and negative results. The biomarker must be able to clearly reflect the early stage of disease and it must be easily detected without complicated medical procedures. The disease markers released to serum and urine are good targets for application of early screening. The method for screening should be cost effective. Biomarkers are commonly detected through blood, urine, other body fluids, and tissue samples.

Biomarkers play a major role in medicinal biology. Biomarkers bring the future things in our hand by helping in early diagnosis, disease prevention, drug target identification, drug response etc. Several disease-based biomarkers had been identified for many diseases such as serum LDL for cholesterol, blood pressure, P53 gene and MMPs for cancer. Gene based biomarkers are found to be effective and acceptable markers in the present scientific world.

RSS Feeds

Biomarkers market research reports and industry analysis

< prev 1    3  4  5  6  
Biomarker Partnering Terms and Agreements
4/1/2014 | published by: Current Partnering
... in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to ...  |  read more...
$2,995.00
MicroRNAs in Cancer Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... with minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us ...  |  read more...
$5,622.50
Conference Documentation: Oncology imaging for drug development
3/12/2014 | published by: SMI Publishing, Ltd
... consider the current landscape of personalised imaging within the field of oncology. SMi's 10th annual event on oncology imaging will provide delegates with a comprehensive insight into current and future legislation and its impact on ...  |  read more...
$788.78
Cardiac Biomarkers: Technologies and Global Markets
3/1/2014 | published by: BCC Research
... to reach $7.2 billion by 2018, at a compound annual growth rate (CAGR) of 12.8% over the five-year period from 2013 to 2018. This report provides: An overview of the global market for biomarkers for ...  |  read more...
$6,650.00
Biomarker Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
$1,495.00
World Tumor Markers Testing Market 2014: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
1/22/2014 | published by: Venture Planning Group
... years - Examines trends in the U.S., Europe and Japan - Reviews current and emerging tumor markers - Analyzes applications of emerging diagnostic technologies - Forecasts sales of major tumor markers by country and market ...  |  read more...
$32,500.00
GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)
1/5/2014 | published by: Kelly Scientific Publications
... Trends, and Pipeline Analysis)” by Kelly Scientific Publications is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized ...  |  read more...
$3,400.00
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective - Overview
12/1/2013 | published by: CHI Insight Pharma Reports
... mostly pertaining to epigenetic targets, and the reasons they are being investigated. Several companies have kindly disclosed several strategies, methods, and techniques that they use for either target identification or technology development. Report Features Include: ...  |  read more...
$2,495.00
Global Epigenetics Market 2014-2018
11/29/2013 | published by: Infiniti Research Limited - TechNavio
... be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provide the most accurate and detailed ...  |  read more...
$2,000.00
Global Imaging Biomarkers Market 2014-2018
11/22/2013 | published by: Infiniti Research Limited - TechNavio
... cancer. The Global Imaging Biomarkers market has also been witnessing the emergence of personalized medicines. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market. TechNavio's report, the ...  |  read more...
$2,000.00
Biomarkers: Discovery Techniques and Applications - A Global Market Overview
11/8/2013 | published by: Industry Experts
... is immense, which has ensued in a large number of scientific publications coming out over the past two decades. Biomarker research encompasses widespread fields of discipline, which comprise drug discovery, toxicity, clinical markers of efficacy ...  |  read more...
$4,500.00
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)
10/16/2013 | published by: Kalorama Information
... medicine. Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease.  With them, diseases are detected earlier, more effective treatments can ...  |  read more...
$3,995.00
Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018
9/30/2013 | published by: MarketsandMarkets
... significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profiling market is valued at $14.99 billion in 2013 ...  |  read more...
$4,650.00
Global MicroRNA Market 2012-2016
9/27/2013 | published by: Infiniti Research Limited - TechNavio
... the increase in microRNA research funding. The Global MicroRNA market has also been witnessing the discovery and development of microRNAs as biomarkers for diseases. However, the high R&D costs could pose a challenge to the ...  |  read more...
$2,500.00
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends and Forecasts (2013 – 2
9/25/2013 | published by: MarketsandMarkets
... and measurable characteristic, which identifies the severity and/or occurrence of a specific disease. It has major applications in the discovery and development of novel therapeutic drugs. The global biomarkers market shows a high growth potential ...  |  read more...
$4,650.00
Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016
9/6/2013 | published by: Infiniti Research Limited - TechNavio
... contributing to this market growth is the rising diagnosis and treatment rates. The Global MS Therapeutics market has also been witnessing the emergence of biomarkers. However, the lack of therapies available to manage the progression ...  |  read more...
$2,500.00
Global Analysis of MicroRNA Tools and Services Market
9/2/2013 | published by: Frost & Sullivan
... 2 major segments – tools and services. MicroRNA tools market is further segmented into qRT-PCR, microarrays, and functional tools, while services market is further segmented into expression profiling and analysis and phenotypic analysis. The study ...  |  read more...
$10,000.00
Biomarker Partnering Terms and Agreements
9/1/2013 | published by: Current Partnering
... in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to ...  |  read more...
$2,795.00
Companion Biomarkers in Drug Development
8/1/2013 | published by: TriMark Publications
... companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid to therapeutic use in the clinic. Market opportunities for companion biomarkers are focused in drug development targets, ...  |  read more...
$3,400.00
Biomarkers: Technological and Commercial Outlook 2013-2023
7/23/2013 | published by: Visiongain
... for sales growth, also understanding trends and opportunities. That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. See what's happening for those technologies, finding how you can gain. ...  |  read more...
$2,633.00
The 2013-2018 Outlook for Cardiac Biomarkers in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
The 2013-2018 Outlook for Biosensors in the United States
7/17/2013 | published by: Icon Group International, Inc.
... dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United ...  |  read more...
$495.00
The 2013-2018 Outlook for Biomarkers in the United States
7/17/2013 | published by: Icon Group International, Inc.
... dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United ...  |  read more...
$495.00
The 2013-2018 World Outlook for Biomarkers
7/15/2013 | published by: Icon Group International, Inc.
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a ...  |  read more...
$795.00
The 2013-2018 World Outlook for Cardiac Biomarkers
7/15/2013 | published by: Icon Group International, Inc.
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly ...  |  read more...
$795.00
< prev 1    3  4  5  6  
 
Our Clients